Allianz Asset Management
KIN

Allianz Asset Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Allianz Asset Management’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-670,262
Closed -$6.15M – 2708
2021
Q2 		$6.15M Buy
670,262
+192,960
+40% +$1.12M 0.01% 1022
2021
Q1 		$2.37M Buy
477,302
+86,760
+22% +$419K ﹤0.01% 1344
2020
Q4 		$1.68M Buy
390,542
+45,423
+13% +$185K ﹤0.01% 1359
2020
Q3 		$1.48M Sell
345,119
-56,276
-14% -$235K ﹤0.01% 1339
2020
Q2 		$1.8M Sell
401,395
-299,089
-43% -$1.34M ﹤0.01% 1649
2020
Q1 		$2.8M Buy
700,484
+29,225
+4% +$248K ﹤0.01% 1408
2019
Q4 		$5.69M Sell
671,259
-50,276
-7% -$392K 0.01% 1424
2019
Q3 		$4.95M Buy
721,535
+288,404
+67% +$2.12M ﹤0.01% 1446
2019
Q2 		$3.61M Buy
433,131
+94,091
+28% +$812K ﹤0.01% 1655
2019
Q1 		$3.11M Buy
339,040
+92,850
+38% +$943K ﹤0.01% 1668
2018
Q4 		$2.7M Sell
246,190
-4,777
-2% -$60.2K ﹤0.01% 1645
2018
Q3 		$3.5M Buy
+250,967
New +$3.4M ﹤0.01% 1715
2014
Q3 		– Sell
-88,490
Closed -$1.65M – 2392
2014
Q2 		$1.65M Buy
+88,490
New +$1.5M ﹤0.01% 1268

Other funds holding KIN

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Allianz Asset Management's KIN Position: Q3 2021 in Review

Allianz Asset Management sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 670,262 shares — an estimated $6.15M sold.

Allianz Asset Management first reported a position in KIN in Q2 2014 and held it in 13 quarters. The position peaked at $6.15M in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • Allianz Asset Management reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Allianz Asset Management sold 670,262 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $6.15M.
  • Allianz Asset Management first reported a position in Kindred Biosciences, Inc. in Q2 2014 and held it in 13 quarters.
  • Allianz Asset Management's Kindred Biosciences, Inc. position peaked at $6.15M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Allianz Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.